Oct 2 |
Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
|
Sep 9 |
Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
|
Sep 5 |
Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now
|
Aug 26 |
We're Hopeful That Xenon Pharmaceuticals (NASDAQ:XENE) Will Use Its Cash Wisely
|
Aug 21 |
Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe
|
Aug 12 |
Xenon names Matthew Ronsheim as chief operating officer
|
Aug 12 |
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
|
Aug 9 |
Xenon Pharmaceuticals: Good Data In Epilepsy, But Doubts Remain
|
Aug 9 |
Xenon Pharma files for automatic mixed securities shelf
|
Aug 9 |
Xenon Pharmaceuticals, Inc. (XENE) Q2 2024 Earnings Call Transcript
|